Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1128437

	registered interest
	date	23/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether (a) NICE and (b) NHS England take into account the availability of medicines under the Early Access to Medicines Scheme when assessing those same medicines for approval as new medicines.
	tabling member constituency	Bolton West
	tabling member printed	Chris Green
	uin	257759
	answer	answer is ministerial correction date of answer 07/06/2019 answer text <p>The National Institute for Health and Care Excellence takes into account the availability of medicines through the Early Access to Medicines Scheme (EAMS) in terms of scheduling its assessments, however the process followed in assessing the technology is the same as for non-EAMS technologies.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 07/06/2019 14:54:05 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4398 label Biography information for Chris Green

1128441

	registered interest
	date	23/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the accuracy of evidence base on the cost-effectiveness of medical cannabis.
	tabling member constituency	Hemel Hempstead
	tabling member printed	Sir Mike Penning
	uin	257705
	answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>An initial impact assessment was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. This can be viewed at the following link:</p><p><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></p><p>This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of cannabis-based products for medicinal use (CBPM). This framework included potential savings in treatment costs, giving the example of patients with severe epilepsy for whom medicinal use of cannabis could reduce the frequency of seizures and reduce the number of related hospital admissions. This was an initial framework for assessing this policy and as we develop our knowledge in this area, both on the costs and the potential benefits, we can revisit and refine these assessments.</p><p>In the meantime, the National Institute for Health and Care Excellence (NICE) is developing clinical guidelines on the appropriate use of CBPM based on the best available evidence, and the National Institute for Health Research is funding further clinical research on this. More information is available at the following link:</p><p><a href="https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf" target="_blank">https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 13:23:02 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1528 label Biography information for Sir Mike Penning

1128442

	registered interest
	date	23/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will publish the evidence (a) his Department and (b) the Department for International Trade holds on growing a market for prescribed medicinal cannabis.
	tabling member constituency	Hemel Hempstead
	tabling member printed	Sir Mike Penning
	uin	257706
	answer	answer is ministerial correction date of answer 10/06/2019 answer text <p><ins class="ministerial"> <p><ins class="ministerial">The Department for International Trade and the Department of Health and Social Care are not specifically collecting data on the growth of the market for cannabis based products for medicinal use in the United Kingdom.</ins></p><p><ins class="ministerial">However, data from the Medicines and Healthcare products Regulatory Agency (MHRA) shows growing numbers of import notifications for medicinal cannabis and the Home Office has received increased numbers of licence applications.</ins></p><p><ins class="ministerial">In addition, UK companies exporting these products and foreign companies looking to invest in the UK have full access to government support, where they have the necessary authorisations from the MHRA and Home Office and a relevant Export Licence.</ins></p></ins></p><p><del class="ministerial">An initial impact assessment was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. This can be viewed at the following link:</del></p><p><del class="ministerial"><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></del></p><p><del class="ministerial">This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of cannabis-based products for medicinal use (CBPM). This framework included potential savings in treatment costs, giving the example of patients with severe epilepsy for whom medicinal use of cannabis could reduce the frequency of seizures and reduce the number of related hospital admissions. This was an initial framework for assessing this policy and as we develop our knowledge in this area, both on the costs and the potential benefits, we can revisit and refine these assessments.</del></p><p><del class="ministerial">In the meantime, the National Institute for Health and Care Excellence (NICE) is developing clinical guidelines on the appropriate use of CBPM based on the best available evidence, and the National Institute for Health Research is funding further clinical research on this. More information is available at the following link:</del></p><p><del class="ministerial"><a href="https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf" target="_blank">https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf</a></del></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 13:18:03 question first ministerially corrected 11/06/2019 11:31:21 answering member 4455 label Biography information for Seema Kennedy previous answer version 121340 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
	tabling member	1528 label Biography information for Sir Mike Penning

1128443

	registered interest
	date	23/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when he plans to publish the interim report produced by NHS England to identify the barriers that are blocking access to prescribed medicinal cannabis by patients.
	tabling member constituency	Hemel Hempstead
	tabling member printed	Sir Mike Penning
	uin	257707
	answer	answer is ministerial correction date of answer 07/06/2019 answer text <p>The NHS England process review is underway and interviews are scheduled to take place over June 2019. The interim report will not be published, as by its nature any findings will be incomplete. The Government is, however, committed to publishing a summary of the final findings and recommendations before summer recess.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 257708 question first answered 07/06/2019 14:49:30 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1528 label Biography information for Sir Mike Penning

1128444

	registered interest
	date	23/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when he plans to publish the final report by NHS England to identify the barriers that are blocking access to prescribed medicinal cannabis by patients.
	tabling member constituency	Hemel Hempstead
	tabling member printed	Sir Mike Penning
	uin	257708
	answer	answer is ministerial correction date of answer 07/06/2019 answer text <p>The NHS England process review is underway and interviews are scheduled to take place over June 2019. The interim report will not be published, as by its nature any findings will be incomplete. The Government is, however, committed to publishing a summary of the final findings and recommendations before summer recess.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 257707 question first answered 07/06/2019 14:49:30 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1528 label Biography information for Sir Mike Penning

1128505

	registered interest
	date	23/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Primary Care Networks: General Practitioners
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether safeguards are in place to ensure that patients' rights to continuity of care with their named GP will be protected in the new Primary Care Network contract, published in March 2019.
	tabling member constituency	Colne Valley
	tabling member printed	Thelma Walker
	uin	257814
	answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>The new Primary Care Network arrangements will not prevent patients seeing their preferred professional at their practice. The core general practice contract will still include a requirement for each contractor to ensure that for each of its registered patients, there is assigned an accountable general medical practitioner (an ‘accountable GP’).</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 15:24:15 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4649 label Biography information for Thelma Walker

1128560

	registered interest
	date	23/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Food: Advertising
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the potential reduction in daily calories consumed by children as a result of (a) the consultation on restricting promotions of food and drink that is high in fat, sugar and salt consultation and (b) further advertising restrictions on such products.
	tabling member constituency	Linlithgow and East Falkirk
	tabling member printed	Martyn Day
	uin	257781
	answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>Estimates of the potential reduction in daily calories consumed by children as a result of the measures set out in the consultations on restricting promotions of products high in fat, sugar and salt, and introducing further advertising restrictions on such products are provided in the impact assessments published alongside each consultation. These are available at the following links:</p><p> </p><p>‘Restricting volume promotions for high fat, sugar and salt (HFSS) products’ impact assessment:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/770705/impact-assessment-for-restricting-volume-promotions-for-HFSS-products.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/770705/impact-assessment-for-restricting-volume-promotions-for-HFSS-products.pdf</a></p><p>‘Restricting checkout, end-of-aisle, and store entrance sales of food and drinks high in fat, salt and sugar (HFSS) impact assessment:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/770706/impact-assessment-restricting-checkout-end-of-aisle-and-store-entrance-sales-of-HFSS.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/770706/impact-assessment-restricting-checkout-end-of-aisle-and-store-entrance-sales-of-HFSS.pdf</a></p><p>‘Introducing a 2100-0530 watershed on TV advertising of HFSS (food and drink that are High in Fat, Salt and Sugar) products and similar protection for children viewing adverts online’ impact assessment:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/786554/advertising-consultation-impact-assessment.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/786554/advertising-consultation-impact-assessment.pdf</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 15:26:39 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4488 label Biography information for Martyn Day

1128206

	registered interest
	date	22/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Obstructive Pulmonary Disease
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many emergency ambulance dispatches were made for chronic obstructive pulmonary disease in areas with high levels of air pollution during April 2019; and what comparative assessment he has made of those figures and the average number of dispatches for that disease in April over the last (a) 20, (b) 10 and (c) five years.
	tabling member constituency	Southampton, Test
	tabling member printed	Dr Alan Whitehead
	uin	257381
	answer	answer is ministerial correction date of answer 07/06/2019 answer text <p>According to the Daily Air Quality Index there were ‘moderate’ to ‘very high’ levels of air pollution in some areas of the United Kingdom between 7 and 8 April and between 15 to 25 April 2019. The figures for emergency hospital admissions for chronic obstructive pulmonary disease (COPD) in this period are not available in the requested format and a comparative assessment has not been made.</p><p>In January 2019, the Government launched the Clean Air Strategy, which sets out plans for dealing with all sources of air pollution to save lives and protect nature.</p><p>The Department collaborated with the National Review of Asthma Deaths led by the Royal College of Physicians which examined the circumstances surrounding deaths from asthma and reported in 2015. Lessons learned about the factors that contribute to COPD deaths inform the National Health Service about what constitutes good care, and encourages the development of appropriate services for people with asthma.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 07/06/2019 14:59:08 answering member 4455 label Biography information for Seema Kennedy
	tabling member	62 label Biography information for Dr Alan Whitehead

1128207

	registered interest
	date	22/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Strokes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many emergency ambulance dispatches there were for stroke in areas of high levels of air pollution during April 2019; and what comparative assessment he has made of those figures and the average number of dispatches in April over the last (a) 20, (b) 10 and (c) five years.
	tabling member constituency	Southampton, Test
	tabling member printed	Dr Alan Whitehead
	uin	257382
	answer	answer is ministerial correction date of answer 07/06/2019 answer text <p>According to the Daily Air Quality Index there were ‘moderate’ to ‘very high’ levels of air pollution in some areas of the United Kingdom between 7 and 8 April and between 15 to 25 April 2019. The figures for emergency ambulance dispatches for stroke in this period are not available in the requested format and a comparative assessment has not been made.</p><p>In January 2019, the Government launched the Clean Air Strategy, which sets out plans for dealing with all sources of air pollution to save lives, protect nature and boost the economy.</p><p>Preventing stroke is one of NHS England’s priorities and, following the publication of the NHS Long Term Plan in January 2019, NHS England has been working closely with the Stroke Association to develop a national stroke programme to be delivered within the timescale of this plan.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 07/06/2019 14:57:45 answering member 4455 label Biography information for Seema Kennedy
	tabling member	62 label Biography information for Dr Alan Whitehead

1128232

	registered interest
	date	22/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people are participating in the PrEP Impact Trial; and what assessment he has made of the adequacy of the number of spaces available on that trial on the 31 May 2019.
	tabling member constituency	West Ham
	tabling member printed	Lyn Brown
	uin	257453
	answer	answer is ministerial correction date of answer 07/06/2019 answer text <p>With the expansion of 13,000 additional places for the pre-exposure prophylaxis (PrEP) Impact Trial in February 2019, the total PrEP Impact Trial size is 26,000 places in England.</p><p>PrEP Trial recruitment monitoring is regularly reported to the programme oversight board, the trial steering committee, and the trial management group to continually assess the capacity to answer trial study objectives. The Board met on 20 March and received an update on trial site capacity and commissioner approvals of additional trial places. More information on the release of trial places is available at the following link:</p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/#April" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/#April</a></p><p>Further information on the PrEP Impact Trial can be found at the following link:</p><p><a href="https://www.prepimpacttrial.org.uk/" target="_blank">https://www.prepimpacttrial.org.uk/</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 07/06/2019 14:39:58 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1583 label Biography information for Ms Lyn Brown